Beijing Sunho Pharmaceutical Co., Ltd
About Beijing Sunho Pharmaceutical Co., Ltd
Certifications
Categories
-
Country/Region:China
-
On CPHI since:2024
-
Certificates:3
-
Employees:500 - 999
Company types
Primary activities
Products from Beijing Sunho Pharmaceutical Co., Ltd (3)
-
Product Tranexamic Acid Injection
Strength: 500mg/5mL, 1000mg/10mL
Packaging: vial, amouple
Indication: for the prevention and treatment of hemorrhagic episodes due to increased fibrinolysis (hyperfibrinolysis), including surgical and traumatic hemorrhage and postpartum hemorrhage.
Status: approved in Germany and Poland -
Product Docetaxel Injection
Strength: 20mg : 1mL; 80mg : 4mL
Packaging: vial
Indication: for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancer, as monotherapy or in combination regimens as appropriate.
Status: US FDA approved -
Product Articaine HCl and Epinephrine Injection
Strength: 1.7 mL : 4% Articaine HCl and Epinephrine (Bitartrate)
Packaging: Cartridge
Indication: Anesthetic for dental surgery
Beijing Sunho Pharmaceutical Co., Ltd Resources (2)
-
News Top 20 Chinese CDMO Enterprises in 2025
Beijing Sunho Pharmaceutical was honored once again as one of the top 20 Chinese pharmaceutical CDMO enterprises in 2025.


